The success of CAR-Ts in oncology has stoked enthusiasm for developing comparable curative therapies in other disease areas. CellProthera’s Chief Scientific Officer, Ibon Garitaonandia, explains the ...

Cancer Research UK-funded researchers aim to identify targets for an ovarian cancer vaccine, which could prevent the disease at an early stage. It has been announced that a new study will commence, ...

Researchers have identified underlying KRAS mutations which drive associated risk of particular clinical outcomes.

Results from Pistoia Alliance’s Lab of the Future survey has shared important findings about the challenges life science companies face.

Researchers have identified underlying KRAS mutations which drive associated risk of particular clinical outcomes. Researchers at Weill Cornell Medicine, New York-Presbyterian and Memorial Sloan ...

Sphere Fluidics have developed the Cyto-Mine® Chroma platform, which provides multiplexing and greater assay flexibility, reducing timelines and cost.

Researchers at the University of California San Diego have discovered two distinct molecular subtypes of Crohn’s disease by studying organoids derived from adult stem cells in the intestine tissue ...

Join this webinar to discover how GPCR functional, cell-based assays determine off-target effects, reveal safety issues, and define drug mechanism of action to ultimately evaluate the therapeutic ...

Results from Pistoia Alliance’s Lab of the Future survey has shared important findings about the challenges life science companies face. The results from The Pistoia Alliance’s Lab of the Future ...

The study’s findings could contribute to future therapeutic strategies to prevent chronic kidney disease. Researchers from University of Southern California (USC) and California Institute of ...

Tune into this episode where we investigate how antibody drug conjugates can be optimised, as well as the future of the field.